therapeutic option

  1. C

    Targeting the Monocytic-Endothelial-Platelet Axis with Maraviroc and Pravastatin as a Therapeutic Option to Treat Long COVID...(Patterson et al, 2022)

    Targeting the Monocytic-Endothelial-Platelet Axis with Maraviroc and Pravastatin as a Therapeutic Option to Treat Long COVID/ Post-Acute Sequelae of COVID (PASC) Bruce Patterson et al, 2022 Abstract Post-acute sequelae of COVID (PASC), or long COVID, is a multisystem complication of...
Back